Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) was the target of a significant growth in short interest during the month of August. As of August 14th, there was short interest totaling 113,543 shares, a growth of 343.9% from the July 30th total of 25,578 shares. Based on an average trading volume of 141,285 shares, the short-interest ratio is currently 0.8 days. Approximately 1.7% of the company’s shares are sold short.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on OXBR. Weiss Ratings raised Oxbridge Re from a “sell (d-)” rating to a “sell (d+)” rating in a research report on Friday, August 14th. Zacks Research downgraded shares of Oxbridge Re from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 18th. Finally, Maxim Group reduced their price target on shares of Oxbridge Re from $5.00 to $3.00 and set a “buy” rating on the stock in a research report on Tuesday, June 16th. One investment analyst has rated the stock with a Buy rating and two have given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Reduce” and an average target price of $3.00.
Check Out Our Latest Research Report on OXBR
Hedge Funds Weigh In On Oxbridge Re
Oxbridge Re Stock Performance
Shares of OXBR traded down $0.01 during midday trading on Wednesday, hitting $1.28. 301 shares of the stock traded hands, compared to its average volume of 287,840. Oxbridge Re has a 1-year low of $0.66 and a 1-year high of $2.86. The firm has a market capitalization of $10.46 million, a PE ratio of 64.28 and a beta of 1.94. The business’s 50 day moving average price is $1.34 and its two-hundred day moving average price is $1.08.
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The insurance provider reported $0.02 EPS for the quarter, missing the consensus estimate of $0.03 by ($0.01). Oxbridge Re had a net margin of 4.71% and a return on equity of 2.14%. The firm had revenue of $0.94 million during the quarter, compared to analyst estimates of $1.10 million. As a group, equities research analysts forecast that Oxbridge Re will post -0.08 EPS for the current fiscal year.
Oxbridge Re Company Profile
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Further Reading
- Five stocks we like better than Oxbridge Re
- OpenAI’s Jalapeño Chip Could Change the AI Hardware Race
- Gold and Bitcoin Are Rebounding—2 ETFs Give Investors a Different Kind of Exposure
- HONA: The Spin-Off Story the Market Is Reading Wrong
- Quantum Computing Is Raising the Stakes for Cybersecurity: 5 Stocks to Watch
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
